Ifrah Financial Services Inc. decreased its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 66.4% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,032 shares of the semiconductor company's stock after selling 2,044 shares during the quarter. Ifrah Financial Services Inc.'s holdings in Synopsys were worth $449,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds have also modified their holdings of the business. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new position in Synopsys during the second quarter valued at approximately $747,400,000. Man Group plc purchased a new stake in Synopsys in the 2nd quarter worth approximately $55,900,000. Nykredit A S purchased a new stake in Synopsys in the 2nd quarter worth approximately $23,158,000. Bank of America Corp DE acquired a new stake in shares of Synopsys during the 2nd quarter valued at $539,986,000. Finally, Integrated Wealth Concepts LLC boosted its stake in shares of Synopsys by 88.6% during the 2nd quarter. Integrated Wealth Concepts LLC now owns 6,816 shares of the semiconductor company's stock valued at $3,040,000 after buying an additional 3,202 shares during the period. Hedge funds and other institutional investors own 85.47% of the company's stock.
Synopsys Price Performance
Shares of SNPS opened at $494.51 on Wednesday. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 1.34. The firm has a market cap of $94.77 billion, a PE ratio of 87.37, a PEG ratio of 2.05 and a beta of 1.21. The firm's 50 day moving average price is $423.97 and its 200 day moving average price is $440.26. Synopsys, Inc. has a twelve month low of $362.55 and a twelve month high of $539.48.
Synopsys (NASDAQ:SNPS - Get Free Report) last posted its earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 EPS for the quarter, topping the consensus estimate of $3.67 by $0.24. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. The company had revenue of $2.48 billion during the quarter, compared to the consensus estimate of $2.44 billion. During the same period in the previous year, the firm posted $3.39 earnings per share. The company's revenue for the quarter was up 42.4% compared to the same quarter last year. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. As a group, research analysts expect that Synopsys, Inc. will post 10.97 EPS for the current fiscal year.
Synopsys declared that its Board of Directors has approved a share buyback plan on Monday, October 5th that authorizes the company to buy back $1.00 billion in outstanding shares. This buyback authorization authorizes the semiconductor company to reacquire up to 1.1% of its stock through open market purchases. Share buyback plans are generally an indication that the company's leadership believes its stock is undervalued.
Analysts Set New Price Targets
SNPS has been the topic of several research analyst reports. Roth Capital upgraded shares of Synopsys to a "buy" rating in a report on Friday, September 25th. Benchmark reiterated a "buy" rating and set a $570.00 price objective on shares of Synopsys in a report on Thursday, August 27th. Sanford C. Bernstein started coverage on Synopsys in a report on Friday, September 25th. They set an "outperform" rating for the company. Deutsche Bank Aktiengesellschaft reissued a "buy" rating and set a $640.00 price objective (up from $590.00) on shares of Synopsys in a research report on Thursday, October 1st. Finally, UBS Group set a $570.00 target price on Synopsys in a research note on Thursday, August 27th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-one have assigned a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, Synopsys presently has an average rating of "Moderate Buy" and a consensus price target of $571.78.
Check Out Our Latest Research Report on Synopsys
Insider Buying and Selling at Synopsys
In other Synopsys news, insider Aart de Geus sold 24,641 shares of the firm's stock in a transaction dated Tuesday, September 1st. The stock was sold at an average price of $419.44, for a total transaction of $10,335,421.04. Following the transaction, the insider directly owned 120,443 shares in the company, valued at $50,518,611.92. This trade represents a 16.98% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Janet Lee sold 1,144 shares of the firm's stock in a transaction dated Tuesday, October 6th. The shares were sold at an average price of $502.52, for a total value of $574,882.88. Following the transaction, the insider owned 16,534 shares in the company, valued at approximately $8,308,665.68. This trade represents a 6.47% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 102,559 shares of company stock valued at $44,607,141. Company insiders own 0.56% of the company's stock.
Synopsys Profile
(
Free Report)
Synopsys, Inc is a technology company that develops electronic design automation (EDA) software, semiconductor intellectual property (IP), and software tools used to design, verify, and manufacture advanced electronic systems. Its solutions support the development of semiconductors, systems-on-chip, and electronic products across the design cycle, from initial specification and architecture through testing and production.
The company's offerings include digital and custom integrated-circuit design tools, simulation and verification software, physical design and signoff products, and semiconductor IP such as processor cores, interface technologies, and foundational components.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.